Media Coverage · April 18, 2019

New antiplatelet may lower bleeding risk in stroke

April 2019. The novel antiplatelet agent ACT017 confers reduced risk for bleeding in healthy volunteers and may be a safe and effective alternative for patients with stroke, according to early findings published in Arteriosclerosis, Thrombosis and Vascular Biology.

Read full article 

Read next in 'Media Coverage'